Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market To Reach USD 783 Million By 2026 | Reports And Data New york, Nov. 18, 2019 (GLOBE NEWSWIRE) -- High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research funding...